

  











<!doctype html>
<html>
<head>
    <meta charset="utf-8">
    
        <meta name="viewport" content="width=device-width,initial-scale=1">
    
    
    
    
    
    
    
        
            <title>Research update from the MCM team (September 2023)</title>
        
        
    
    
    
    
    
        


<meta name="Description" content="World Community Grid enables anyone with a computer, smartphone or tablet to donate their unused computing power to advance cutting-edge scientific research on topics related to health, poverty and sustainability."/>
<meta name="Keywords" content="World Community Grid, Volunteer Computing, Let your computer daydream science"/>










<meta property="og:url" content="https://www.worldcommunitygrid.org/about_us/article.s?articleId=802" />
<meta property="og:type" content="website" />
<meta property="og:locale" content="en_US" />
<meta property="og:title" content="Research update from the MCM team (September 2023)" />
<meta property="og:description" content="The MCM team’s analysis has shown that ovarian cancer results were dishomogeneous. We will begin running additional ovarian work units starting September 25th." />
<meta property="og:image" content="https://www.worldcommunitygrid.org/images/prismic/mcm_fullbodied_update.png" />
<meta property="og:image:secure_url" content="https://www.worldcommunitygrid.org/images/prismic/mcm_fullbodied_update.png" />
<meta property="og:image:width" content="676" />
<meta property="og:image:height" content="380" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:site" content="@WCGrid" />
<meta name="twitter:creator" content="@WCGrid" />


    
    
    
    <script>
    var WCG = {};
    WCG.facebook = {};
    WCG.facebook.app_id=112250102148804;
    WCG.locale = {};
    WCG.locale.language='en';
    WCG.locale.country='US';
</script>

    
    
        
<link rel="stylesheet" type="text/css" href="/generated/css/wcg_8ff7f2b046.css" />
<script src="/generated/js/wcg_8a248d7cc7.js"></script>
<script>
	var $j = jQuery.noConflict();
</script>

    
        <link rel="stylesheet" type="text/css" href="/css/lib/jquery-ui-1.11.4/jquery-ui.min.css" />
<link rel="stylesheet" type="text/css" href="/css/lib/jquery-ui-1.11.4/jquery-ui.override.css" />
<script type="text/javascript">
	var $ = $j;
</script>
<script src="/js/lib/jquery-ui-1.11.4/jquery-ui.min.js" ></script>

    
        <script src="/js/lib/jquery.slides.min.js" ></script>
<link rel="stylesheet" type="text/css" href="/css/feature/news-slideshow-styles.css">

    
    
    
    
    
    
    <link href="/static/css/2.7b4bf2a7.chunk.css" rel="stylesheet"/>
<link href="/static/css/main.a189a511.chunk.css" rel="stylesheet"/>

</head>


    <body class="">


    <div class="wcg-legacy-layout wcg-legacy-vertical-flex-container" >
        


    


    

<div id="header" class="header__container" data-context-type="main" data-context-section="" data-context-highlight="News"></div>
        <div id="top" class="wcg-legacy-vertical-flex-item wcg-legacy-vertical-flex-container">
            
            
            <div class="wcg-legacy-vertical-flex-item " >
	            
	            <div class="bx--grid" style="width: 100%">
	                <div class="bx--row">
	                    <div class="bx--col-sm-4 bx--col-md-8 bx--offset-lg-3 bx--col-lg-10 bx--offset-xlg-4 bx--col-xlg-8">

	                    <div class="wcg-legacy wcg-body-padding">
	                        










<main>
    <div id="newsArticleContent" class="news-article">
    <nav class="bx--breadcrumb" aria-label="breadcrumb">
        <div class="bx--breadcrumb-item">
            <a href="/about_us/news.s" class="bx--link" >News</a>
        </div>
    </nav>
    <h1>Research update from the MCM team (September 2023)</h1>
	    <article class="middle-article">
	        
		        <br/>
		        <p>The MCM team’s analysis has shown that ovarian cancer results were dishomogeneous. We will begin running additional ovarian work units starting September 25th.</p>
	        
	        <hr/>
	        
			
				<p class="related-items"><span class="related-items-title">Project: </span>
				  
				  <a class="related-items-link" href="/research/mcm1/overview.do">Mapping Cancer Markers</a>
				</p>
			
	        
	        <p class="related-items"><span class="related-items-title">Published on: </span>22 Sep 2023</p>
	        <hr style="margin-top:15px;"/>
	        <section>
	            <span><p><strong>Terminology</strong></p>

<ul>
	<li style="line-height: 1.38;"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><strong>Gene signature:</strong> A set of genes shown to have a specific role in a disease is called gene signature. When such a signature can predict the presence of a disease, it is called a diagnostic gene signature. When signature relates to survival, it is called prognostic signature.&nbsp;</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><strong>Matthews correlation coefficient:</strong> A statistical method used to evaluate the performance of a predictive model. It measures the differences between actual values and the predicted ones.</span></span></span></span></span></span></li>
	<li style="line-height: 1.38;"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:700"><span style="font-style:normal"><span style="text-decoration:none"><strong>Probes:</strong> </span></span></span></span></span></span><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Short DNA sequences targeting a small region of a transcript (gene). To make them more specific, probes are organized into probe sets, which are used to detect and quantify the presence of gene sequences through hybridisation due to complementarity between the probe and the target.&nbsp;</span></span></span></span></span></span></li>
</ul>

<p style="line-height:1.38"><strong>Background</strong></p>

<p style="line-height:1.38"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">The Mapping Cancer Marker project aims to identify biomarkers associated with various cancers. By analyzing millions of data points from patient tissue datasets, we can identify patterns that can enable early detection, identification of high-risk patients, and customization of treatment plans for patients.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">In our <a href="https://www.worldcommunitygrid.org/about_us/article.s?articleId=782">March update</a></span></span></span></span></span></span><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">, we outlined our investigation of lung cancer biomarkers conducted by testing multiple signatures in a dataset of tissues belonging to patients who have a history of lung cancer to find any groups of probes that could indicate the patient has early stage lung cancer. As the work on lung cancer signatures continues, we have started to interpret data from ovarian cancer, which we share in this update.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><strong>Ovarian cancer analysis</strong></p>

<p style="line-height:1.38"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Similarly to our approach with lung cancer, to investigate ovarian cancer biomarkers, we used a collection of multiple datasets with a total of 711 samples. Of the samples, 410 had short survival of under 3 years, and 301 had long survival of over 4 years. Our analyses focused on differentiating patients with long survival from those with a short survival.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Thanks to the help of the WCG volunteers, we were able to test over 160 billion (1.626353x10</span></span></span></span></span></span><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><sup style="font-size:0.6em">11</sup></span></span></span></span></span></span><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">) candidate ovarian cancer signatures across several signature sizes. We then considered the signatures with Matthews correlation coefficient in the 99.999 percentile among all signatures of that same size. Figure 1 shows the distribution of biomarkers in the signatures. Count refers to the number of times a probe is present in the top signatures for its size.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><span style="border:none"><span style="display:inline-block"><span style="overflow:hidden"><span style="width:616px"><span style="height:352px"><img alt="" height="352" src="https://lh5.googleusercontent.com/kb1wK8AsPtTh3ZYywNWZPQmC5YCQzFCDMgWSzvOntfnhPzLBM_tppshIW4D7GmKryUgjGqyLGUuw4GcjOOqAOlWFbKEE9FcCrNusKckuj2GjK4I5BNt7oPVumA_jb72_EZ7nXuJKbkwsMoz453FyX_A" width="616" /></span></span></span></span></span></span></span></span></span></span></span></p>

<p style="line-height:1.38; text-align:center"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">Figure 1. Frequency of each count (i.e., number of times a probe is present) per signature size for ovarian cancer data.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">The lung cancer results, shown in Figure 2, follow a normal distribution of biomarkers across the signatures, while results for ovarian cancer (Figure 1) are not normal. Due to this dishomogeneity in ovarian cancer results, we have decided to run additional ovarian cancer work units. These work units will be sent out starting Monday, September 25th and while they are running, sarcoma work units will be paused.</span></span></span></span></span></span></p>

<p style="line-height: 1.38; text-align: center;"><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none"><span style="border:none"><span style="display:inline-block"><span style="overflow:hidden"><span style="width:619px"><span style="height:352px"><img alt="" height="352" src="https://lh4.googleusercontent.com/STuQLYP00JoSLvY32CJXcZSfbNcO1FtwJVPLzDYNaR-LrBUPVk45XWvjjuh45f_oTjMUK-rPdMUK3bFYTvT_t8vlQc2arIQv41mN7xyPAj_Ca48amCGYgA6_-x_kxmLquMQttJl6HvFqzVCCVEgk_jQ" width="619" /></span></span></span></span></span></span></span></span></span></span></span><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:italic"><span style="text-decoration:none">Figure 2. Frequency of each count (i.e., number of times a probe is present) per signature size for lung cancer data.</span></span></span></span></span></span></p>

<p><span style="font-size:11pt; font-variant:normal; white-space:pre-wrap"><span style="font-family:Arial,sans-serif"><span style="color:#000000"><span style="font-weight:400"><span style="font-style:normal"><span style="text-decoration:none">Thank you for your continued support. If you have any questions or comments, please leave them in <a href="https://www.worldcommunitygrid.org/forums/wcg/viewthread_thread,45747">this thread</a> for us to answer.</span></span></span></span></span></span></p>

<p style="line-height:1.38"><a href="https://www.cs.toronto.edu/~juris/jlab/mcm.html"><span style="white-space-collapse: preserve;">WCG Team</span></a></p>
</span>
	        </section>
            
            
            
	        
	        
	        
	        
	    </article>
    </div>
</main>

	                    </div>
	                    </div>
	                </div>
	            </div>
            </div>
        </div>
        <div id="footer"></div>
    </div>
    
    <script src="/static/js/runtime-main.eec01e85.js">
</script>
<script src="/static/js/2.2593f09a.chunk.js">
</script>
<script src="/static/js/main.859d1bf2.chunk.js">
</script>

    
    




<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-P7SR87"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-P7SR87');</script>



<script>
wcg_init();
</script>
</body>
</html>
